Growth Metrics

Gossamer Bio (GOSS) Income from Continuing Operations (2022 - 2025)

Gossamer Bio's Income from Continuing Operations history spans 4 years, with the latest figure at 47238000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations fell 43.01% year-over-year to 47238000.0; the TTM value through Dec 2025 reached 172994000.0, down 191.67%, while the annual FY2025 figure was 170370000.0, 201.39% down from the prior year.
  • Income from Continuing Operations reached 47238000.0 in Q4 2025 per GOSS's latest filing, up from 48221000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 49267000.0 in Q2 2024 to a low of 59031000.0 in Q3 2022.
  • Average Income from Continuing Operations over 4 years is 40293937.5, with a median of 45991000.0 recorded in 2024.
  • Peak YoY movement for Income from Continuing Operations: surged 215.93% in 2024, then plummeted 177.68% in 2025.
  • A 4-year view of Income from Continuing Operations shows it stood at 57220000.0 in 2022, then rose by 15.85% to 48148000.0 in 2023, then skyrocketed by 31.39% to 33032000.0 in 2024, then crashed by 43.01% to 47238000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Income from Continuing Operations are 47238000.0 (Q4 2025), 48221000.0 (Q3 2025), and 38273000.0 (Q2 2025).